Campbell Roxburgh
@C_Roxburgh
Followers
990
Following
1K
Media
56
Statuses
587
Professor of Colorectal Surgical Oncology, Consultant Surgeon, School of Cancer Sciences, University of Glasgow, Glasgow Royal Infirmary @grisurgery
Glasgow, Scotland
Joined May 2011
Thank you to @epipatelmd for the kind invitation. It’s been fantastic to visit @.@queensu to work on strengthening 🇨🇦 and 🏴 🇬🇧 links and collaborations.
Excited to listen to @C_Roxburgh today at @queensoncology Grand Rounds about IO-RT combination strategies in rectal cancer.
0
5
18
RT @DCRjournal: Post-neoadjuvant modified Glasgow prognostic score associated with poorer response and tumor regression in LARC pots follow….
0
5
0
Congratulations to Josh McGovern on successfully navigating his PhD viva @grisurgery today. 👏👏👏. Thanks to Neil Johns and Rachel Kearns for examining. Fantastic work Josh!
9
3
33
RT @OncoDailyGI: FOxTROT 5 Opens in the UK – New immunotherapy trial for older colon cancer patients - @JenSeligmann.@C_Roxburgh @LTHTResea….
0
5
0
Five Major Advances in Anal and Rectal Cancer Treatment with Radiotherapy: A New Era of Organ-Preserving Options
0
2
4
RT @CRUKScotland: Exciting news for rectal cancer patients - results from a Glasgow clinical trial provide new hope . .
0
7
0
Incredible results from Chinese STELLAR 2 trial in #rectalcancer at #ESTRO25 which shows improved outcomes either immunotherapy and TNT vs TNT alone. Supports SCRT as iTNT backbone.
🔵 #ESTRO25 Press release.#Immunotherapy Combined with #Radiotherapy and #Chemotherapy Reduces the Need for #Surgery in Locally Advanced #rectalcancer. 👉
0
2
7
Interesting/important research from @RK_McMahon @ #ESTRO25 presenting #PREM tools in #rectalcancer trials incorporating extra research biopsies. For pts involved research participation often provided added info/reassurance during RT @UofGCancerSci @RadNetCRUKGla . See poster⬇️
0
4
12
Next step is translational analysis of serial tumour samples to understand . 1. Why tumours respond more or less than others. 2. how RT/anti-PDL1 impacts the TME and response evolution. 👀Watch this space @nigeljamieson @JoanneE59669325 @owen_sansom @AcrCelerate @CRUK_SI.
0
8
19
The PRIME-RT team comprises fantastic clinical/ CTU teams from across the UK - @aberdeenuni, Oxford @TheChristieNHS, @NHSaaa and @UofGlasgow @UofGCancerSci @QUBelfast . We are especially appreciative of the patients who contributed time and energy to be part of the trial.
1
7
14
RT @ESTRO_RT: 🔵 #ESTRO25 Press release.New Study Shows #Immunotherapy and #Radiotherapy Could Help More Rectal Cancer Patients Avoid #Surg….
0
3
0
🇬🇧PRIME-RT results @ESTRO_RT today:. Durvalumab anti-PDL1+SC/LC TNT in #rectalcancer . 52% of pts had CR (pCR/cCR) @ 6mth post-EOT in LARC. ⬆️CR rate w SCRT-Durv - may reflect divergent immune effects of RT on TME . Privileged to be part of incredible ‘Top trials’ session#ESTRO25
3
19
50
RT @Joharrr: !!*RECRUITING*!! .We are looking for an enthusiastic PhD student @CRUK_SI @UofGCancerSci! This exciting fully funded project a….
0
9
0
RT @UofGNews: Elderly colon cancer patients may be able to access a clinical trial that could transform future practice. FOxTROT will tes….
0
8
0
We are excited to be working with @LeedsCTRU and @JenSeligmann on the Foxtrot 5 trial. Improving options for older colon cancer patients and opening up new treatment paradigms! @UofGCancerSci.
The FOxTROT 5 clinical trial will offer elderly people with a specific type of tumour the chance to benefit from an immunotherapy drug called 'dostarlimab' before surgery. Treatment usually involves being given surgery first, which is sometimes followed up by chemotherapy.
0
3
11
RT @OcathailS: Looking forward to hearing @C_Roxburgh present our PRIME RT trial results #ESTRO2025. exciting times in rectal radiation !….
0
5
0
We are so grateful to pts giving their time to participate in research @UofGlasgow at a hugely stressful time. Even more amazing when pts support research publicity interviewing for national press-Thank you Tracey!.
0
4
19